1. Dan Hu, Qiong-, Wang, Hong-Lian, Liu, Jian, Lan, Hui-Yao, Wang, Li. 2023. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2304360. doi:10.1002/advs.202304360. https://pubmed.ncbi.nlm.nih.gov/37749872/
2. Hwang, Soo Seok, Lim, Jaechul, Yu, Zhibin, Li, Hua-Bing, Flavell, Richard A. . mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence. In Science (New York, N.Y.), 367, 1255-1260. doi:10.1126/science.aax0194. https://pubmed.ncbi.nlm.nih.gov/32165587/
3. Mao, Bijing, Zhang, Zhimin, Wang, Ge. 2014. BTG2: a rising star of tumor suppressors (review). In International journal of oncology, 46, 459-64. doi:10.3892/ijo.2014.2765. https://pubmed.ncbi.nlm.nih.gov/25405282/
4. Yuniati, Laurensia, Scheijen, Blanca, van der Meer, Laurens T, van Leeuwen, Frank N. 2018. Tumor suppressors BTG1 and BTG2: Beyond growth control. In Journal of cellular physiology, 234, 5379-5389. doi:10.1002/jcp.27407. https://pubmed.ncbi.nlm.nih.gov/30350856/
5. Duriez, Cyril, Moyret-Lalle, Caroline, Falette, Nicole, El-Ghissassi, Fatiha, Puisieux, Alain. . BTG2, its family and its tutor. In Bulletin du cancer, 91, E242-53. doi:. https://pubmed.ncbi.nlm.nih.gov/15381462/
6. Qi, Fuming, Liu, Wenlong, Tan, Bo, Yang, Jinhui, Liu, Xiaoyun. 2022. BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine. In Frontiers in oncology, 12, 1049928. doi:10.3389/fonc.2022.1049928. https://pubmed.ncbi.nlm.nih.gov/36591524/
7. Zhang, Xiao Zhen, Chen, Mao Jian, Fan, Ping Ming, Jiang, Wei, Liang, Shi Xiong. 2022. BTG2 Serves as a Potential Prognostic Marker and Correlates with Immune Infiltration in Lung Adenocarcinoma. In International journal of general medicine, 15, 2727-2745. doi:10.2147/IJGM.S340565. https://pubmed.ncbi.nlm.nih.gov/35300128/
智鼠故事 
